Workflow
Fresenius Medical Care AG(FMS)
icon
Search documents
Fresenius (FMS) Upgraded to Strong Buy: Here's What You Should Know
ZACKS· 2025-01-07 18:16
Investors might want to bet on Fresenius (FMS) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Since a ...
Best Income Stocks to Buy for January 7th
ZACKS· 2025-01-07 09:26
Stocks with Buy Rank and Strong Income Characteristics - Primo Brands Corporation (PRMB): The Zacks Consensus Estimate for current year earnings has increased by 3.1% over the last 60 days The company has a dividend yield of 1.2%, significantly higher than the industry average of 0.0% [1] - Fresenius Medical Care AG (FMS): The Zacks Consensus Estimate for current year earnings has increased by 1.3% over the last 60 days The company has a dividend yield of 2.0%, compared to the industry average of 0.0% [2] - RB Global, Inc. (RBA): The Zacks Consensus Estimate for current year earnings has increased by 3.8% over the last 60 days The company has a dividend yield of 1.3%, higher than the industry average of 0.0% [2][3]
Best Momentum Stocks to Buy for December 27th
ZACKS· 2024-12-27 16:16
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 27:Payoneer Global Inc. (PAYO) : This financial technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40% over the last 60 days.Payoneer Global's shares gained 33.3% over the last three months compared with the S&P 500’s advanced of 5.0%. The company possesses a Momentum Score of B.TDK Corporation (TTDKY) : This electronic comp ...
Fresenius Medical Care returns to Dax 40 Index
Prnewswire· 2024-12-20 16:23
BAD HOMBURG, Germany, Dec. 20, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, will return to the top tier of the German Stock Index, the DAX 40, as of December 27, 2024. The index represents the performance of the 40 largest publicly traded companies listed on the Frankfurt Stock Exchange and accounts for around 80 percent of the market capitalization of listed stock corporations in Germany. Helen Giza, CEO and Chair ...
Leadership in Dialysis Services and Products Drives FMS Stock
ZACKS· 2024-12-17 14:00
Fresenius Medical Care (FMS) is one of the largest integrated providers of products and services for individuals undergoing dialysis due to chronic kidney failure. Operating through a network of over 3,700 clinics worldwide, the company delivers dialysis services and products across more than 140 countries.Business Segments Driving GrowthFresenius Medical Care reports its operations under two main segments:Care Delivery: This encompasses the company’s Dialysis Services and Care-Coordination (non-dialysis la ...
Is Fresenius Medical Care AG & Co. (FMS) Stock Undervalued Right Now?
ZACKS· 2024-11-11 15:45
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors rely on ...
Fresenius Medical Q3 Earnings Beat Estimates, Operating Margin Rises
ZACKS· 2024-11-06 17:11
Fresenius Medical Care AG & Co. (FMS) reported third-quarter 2024 adjusted earnings per share (EPS) of 45 cents, which surpassed the Zacks Consensus Estimate by 7.1%. The bottom line improved 45.2% year over year.During the reported quarter, the company’s closed divestments included clinic operations in Curacao, Guatemala and Peru.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Revenue DetailRevenues of $5.23 billion (EUR 4,760 million) missed the Zacks Consensus Estimate by 2.4%. T ...
Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?
ZACKS· 2024-11-06 15:55
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores.W ...
Fresenius Medical Care AG(FMS) - 2024 Q3 - Earnings Call Transcript
2024-11-05 19:34
Fresenius Medical Care AG (NYSE:FMS) Q3 2024 Earnings Conference Call November 5, 2024 8:00 AM ET Company Participants Dominik Heger - Head, Investor Relations Helen Giza - Chief Executive Officer and Chair Martin Fischer - Chief Financial Officer Conference Call Participants Richard Felton - Goldman Sachs Victoria Lambert - Berenberg Robert Davies - Morgan Stanley Hugo Solvet - BNP Paribas Oliver Metzger - ODDO BHF Bank Sezgi Oezener - HSBC Giang Nguyen - Citigroup David Adlington - JPMorgan Marianne Bulot ...
Fresenius Medical Care AG(FMS) - 2024 Q3 - Earnings Call Presentation
2024-11-05 17:49
Q3 2024 IR Conference Call Analyst Presentation Helen Giza CEO & Chair of the Management Board Martin Fischer CFO November 5, 2024 | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...